Table 3.
Data and analysis.
| Outcome | Studies | Participants | Statistical method | Effect estimate | |
| 1.1 Pain short term | 6 | 742 | SMDa (IV, Random, 95% CI) | −0.31 (−0.58 to −0.04) | |
|
|
1.1.1 mobile health (mHealth) | 3 | 516 | SMD (IV, Random, 95% CI) | −0.55 (−0.81 to −0.28) |
|
|
1.1.2 Telephone | 3 | 226 | SMD (IV, Random, 95% CI) | −0.04 (−0.30 to 0.22) |
| 1.2 Pain long term | 3 | 416 | SMD (IV, Random, 95% CI) | −0.30 (−0.53 to −0.07) | |
|
|
1.2.1 mHealth | 2 | 280 | SMD (IV, Random, 95% CI) | −0.34 (−0.72 to 0.03) |
|
|
1.2.2 Telephone | 1 | 136 | SMD (IV, Random, 95% CI) | −0.22 (−0.56 to 0.11) |
| 1.3 Physical function short term | 4 | 479 | SMD (IV, Random, 95% CI) | −0.30 (−0.17 to 0.76) | |
|
|
1.3.1 mHealth | 2 | 303 | SMD (IV, Random, 95% CI) | 0.66 (0.18 to 1.13) |
|
|
1.3.2 Telephone | 2 | 176 | SMD (IV, Random, 95% CI) | —0.13 (−0.81 to 0.55) |
| 1.4 Physical function long term | 3 | 416 | SMD (IV, Random, 95% CI) | 0.41 (0.17 to 0.64) | |
|
|
1.4.1 mHealth | 2 | 280 | SMD (IV, Random, 95% CI) | 0.46 (0.08 to 0.84) |
|
|
1.4.2 Telephone | 1 | 136 | SMD (IV, Random, 95% CI) | 0.31 (−0.03 to 0.65) |
| 1.5 Quality of Life short term | 4 | 496 | SMD (IV, Random, 95% CI) | 0.24 (0.05 to 0.43) | |
|
|
1.5.1 mHealth | 2 | 304 | SMD (IV, Random, 95% CI) | 0.27 (0.04 to 0.49) |
|
|
1.5.2 Telephone | 2 | 192 | SMD (IV, Random, 95% CI) | 0.13 (−0.35 to 0.61) |
| 1.6 Quality of Life long term | 3 | 415 | SMD (IV, Fixed, 95% CI) | 0.27 (0.06 to 0.47) | |
|
|
1.6.1 mHealth | 2 | 279 | SMD (IV, Random, 95% CI) | 0.24 (−0.10 to 0.57) |
|
|
1.6.2 Telephone | 1 | 136 | SMD (IV, Random, 95% CI) | 0.33 (0.00 to 0.67) |